Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FX4H8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,878
Award facts
- Contract value 100% obligated
- $15,877.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,877.69 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 16, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. The contract, with an ultimate completion date of January 20, 2026, represents a non-competitive delivery order under AmerSourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the company's facility in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters.
This delivery order is issued under AmerSourceBergen Drug Corp's $999,999,999 comprehensive pharmaceutical supply contract with DLA Troop Support Medical, designated as SPE2DX and running through December 2026. The parent entity, Cencora, Inc. (doing business as AmerSourceBergen), holds a larger IDC valued at up to $999,999,999 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Trelegy Ellipta is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease and asthma, reflecting the breadth of therapeutic domains covered under the DLA's pharmaceutical supply chain supporting Defense Health Agency and military treatment facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FX4H8?
SPE2DR26FX4H8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FX4H8 worth?
The government has obligated $15,878 on SPE2DR26FX4H8.
Is contract SPE2DR26FX4H8 an order under another contract?
Yes. SPE2DR26FX4H8 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4H8 competed?
The extent of competition for SPE2DR26FX4H8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award